Somatic inactivation of the VHL gene in Von Hippel-Lindau disease tumors.
Data up to Jan 2025
Total Citations Per Year
Abstract
References (24)
Identification of the von Hippel-Lindau Disease Tumor Suppressor Gene
1993 • 2,906 citations
5′ CpG island methylation is associated with transcriptional silencing of the tumour suppressor p16/CDKN2/MTS1 in human cancers
1995 • 2,000 citations
Mutations of the VHL tumour suppressor gene in renal carcinoma
1994 • 1,719 citations
Silencing of the VHL tumor-suppressor gene by DNA methylation in renal carcinoma.
1994 • 1,542 citations
Clinical Features and Natural History of von Hippel-Lindau Disease
1990 • 916 citations
Tumor suppressor genes
1991 • 775 citations
Binding of the von Hippel-Lindau Tumor Suppressor Protein to Elongin B and C
1995 • 672 citations
Inhibition of Transcription Elongation by the VHL Tumor Suppressor Protein
1995 • 571 citations
Germline mutations in the von Hippel-Lindau disease tumor suppressor gene: Correlations with phenotype
1995 • 552 citations
Frequent somatic mutations and loss of heterozygosity of the von Hippel-Lindau tumor suppressor gene in primary human renal cell carcinomas.
1994 • 469 citations
DNA methylation and cancer
1994 • 418 citations
Identification of intragenic mutations in the Von Hippel — Lindau disease tumour suppressor gene andcorrelation with disease phenotype
1994 • 386 citations
Somatic mutations of the von Hippel — Lindau disease tumour suppressor gene in non-familial clear cell renal carcinoma
1994 • 371 citations
Elongin (SIII): A Multisubunit Regulator of Elongation by RNA Polymerase II
1995 • 320 citations
Phenotypic expression in von Hippel-Lindau disease: correlations with germline VHL gene mutations.
1996 • 224 citations
Somatic mutations of the von Hippel-Lindau tumor suppressor gene in sporadic central nervous system hemangioblastomas.
1994 • 214 citations
Von Hippel-Lindau (VHL) disease with pheochromocytoma in the Black Forest region of Germany: evidence for a founder effect
1995 • 177 citations
Mutations in the RET proto-oncogene and the von Hippel-Lindau disease tumour suppressor gene in sporadic and syndromic phaeochromocytomas.
1995 • 171 citations
Molecular genetic investigations of the mechanism of tumourigenesis in von Hippel-Lindau disease: analysis of allele loss in VHL tumours
1994 • 150 citations
Molecular genetic diagnosis of von Hippel-Lindau disease in familial phaeochromocytoma.
1995 • 103 citations
Consequences of Direct Genetic Testing for Germline Mutations in the Clinical Management of Families With Multiple Endocrine Neoplasia, Type II
1995 • 103 citations
Molecular analysis of the von Hippel-Lindau disease tumor suppressor gene in human lung cancer cell lines.
1994 • 96 citations
Cytogenetic and fluorescence in situ hybridization studies on sporadic and hereditary tumors associated with von Hippel-Lindau syndrome (VHL)
1994 • 24 citations
A PCR generated AccI RFLP in the 3′ untranslated region of the von Hippel — Lindau disease (VHL) tumour suppressor gene
1994 • 22 citations
Cited By (0)
No citing papers found in database